Cargando…

Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.

Currently, the clinical use of 5-aminolaevulinic acid (ALA)-induced protoporphyrin IX (PPIX) for photodynamic therapy (PDT) is limited by the maximum tolerated oral ALA dose (60 mg kg(-1)). This study investigates whether hydroxypyridinone iron-chelating agents can be used to enhance the tissue leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curnow, A., McIlroy, B. W., Postle-Hacon, M. J., Porter, J. B., MacRobert, A. J., Bown, S. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063198/ https://www.ncbi.nlm.nih.gov/pubmed/9823966

Ejemplares similares

The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon
por: Curnow, A, et al.
Publicado: (2002)

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996)

Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.
por: Messmann, H., et al.
Publicado: (1995)

Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug
por: Curnow, Alison, et al.
Publicado: (2019)

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993)

Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
por: Regula, J., et al.
Publicado: (1994)

Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Grant, W. E., et al.
Publicado: (1994)

Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Loh, C. S., et al.
Publicado: (1992)

The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species
por: Dogra, Yuktee, et al.
Publicado: (2016)

Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.
por: Barr, H., et al.
Publicado: (1987)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
por: Cusnir, Ruslan, et al.
Publicado: (2017)

The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
por: Berg, K., et al.
Publicado: (1996)

The significance of the nature of the photosensitizer for photodynamic therapy: quantitative and biological studies in the colon.
por: Barr, H., et al.
Publicado: (1990)

Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.
por: Bedwell, J., et al.
Publicado: (1992)

Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms
por: Santos, M. Amélia, et al.
Publicado: (2022)

Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver
por: Woodhams, J H, et al.
Publicado: (2004)

Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas.
por: Lofgren, L. A., et al.
Publicado: (1995)

Tuning the properties of tris(hydroxypyridinone) ligands: efficient (68)Ga chelators for PET imaging
por: Imberti, Cinzia, et al.
Publicado: (2019)

Manipulating the In Vivo Behaviour of (68)Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance
por: Imberti, Cinzia, et al.
Publicado: (2020)

An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy
por: Anayo, Lizette, et al.
Publicado: (2018)

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells
por: Sinha, A K, et al.
Publicado: (2006)

Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy
por: Magnussen, Anette, et al.
Publicado: (2021)

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation
por: Wyld, L, et al.
Publicado: (2002)

Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma.
por: Datta, S. N., et al.
Publicado: (1998)

Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism
por: Bourré, L, et al.
Publicado: (2009)

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
por: Cairnduff, F., et al.
Publicado: (1994)

In situ beam reduction of Pu(IV) and Bk(IV) as a route to trivalent transuranic coordination complexes with hydroxypyridinone chelators
por: Carter, Korey P., et al.
Publicado: (2022)

5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts
por: Wang, Xiaochuan, et al.
Publicado: (2017)

Photodynamic detection of a feline meningioma using 5-aminolaevulinic acid hydrochloride
por: Osaki, Tomohiro, et al.
Publicado: (2020)

Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.
por: Tralau, C. J., et al.
Publicado: (1987)

Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours
por: Kelleher, D K, et al.
Publicado: (2003)

Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster.
por: Nuutinen, P. J., et al.
Publicado: (1991)

In vitro studies on the potential use of 5-aminolaevulinic acid-mediated photodynamic therapy for gynaecological tumours.
por: Rossi, F. M., et al.
Publicado: (1996)

The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.
por: Leveckis, J., et al.
Publicado: (1995)

Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro.
por: Wyld, L., et al.
Publicado: (1998)

The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.
por: Wyld, L., et al.
Publicado: (1998)

Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
por: Fernández Guarino, Montserrat, et al.
Publicado: (2022)

Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
por: Messmann, H., et al.
Publicado: (1997)

The detection of phthalocyanine fluorescence in normal rat bladder wall using sensitive digital imaging microscopy.
por: Pope, A. J., et al.
Publicado: (1991)

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
por: Babilas, P, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_3lo1oul33k169eecl4cdromjup